AAAAAA

   
Results: 1-7 |
Results: 7
BIOLOGIC VARIABILITY OF PROSTATE-SPECIFIC ANTIGEN AND ITS USEFULNESS AS A MARKER FOR PROSTATE-CANCER - EFFECTS OF FINASTERIDE
Authors: OESTERLING JE ROY J AGHA A SHOWN T KRARUP T JOHANSEN T LAGERKVIST M GORMLEY G BACH M WALDSTREICHER J LIEBER M HAMPSEY J POULSEN J EKMAN P JOHANSEN TEB HUDSON PB TAMMELA T MUSTONEN S VARENHORST E HJERTBERG H IMPERATOMCGINLEY J GINGELL JC THOMAS SA WOLF H LANGE P ELLIS W BAERT LVM BARTSCH G BEISLAND HO SUGIMOTO D EINARSON GV NURMI M IVERSEN P TOCKER P MALICE MP
Citation: Je. Oesterling et al., BIOLOGIC VARIABILITY OF PROSTATE-SPECIFIC ANTIGEN AND ITS USEFULNESS AS A MARKER FOR PROSTATE-CANCER - EFFECTS OF FINASTERIDE, Urology, 50(1), 1997, pp. 13-18
DIAGNOSIS AND TREATMENT OF ENTEROVESICAL FISTULA
Authors: LARSEN A JOHANSEN TEB SOLHEIM BM URNES T
Citation: A. Larsen et al., DIAGNOSIS AND TREATMENT OF ENTEROVESICAL FISTULA, European urology, 29(3), 1996, pp. 318-321
CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY
Authors: ANDERSEN JT EKMAN P WOLF H BEISLAND HO JOHANSSON JE KONTTURI M LEHTONEN T TVETER K BODKER A VEDEL O NORDLING J POULSEN AL SCHOU J HVIDT V HANSEN JB MEYHOFF HH ELDRUP J HARTWELL D COLSTRUP H LYNGDORF P NIELSEN AH LARSEN E WALTER S LARSEN EH THYBO E MOMMSEN S BROK KE PALM L GENSTER H ANDERSEN M KAUPPINEN P RAUVALA M HAKKINEN J TAMMELA T TAINIO H HYNNINEN O TIITINEN J LEHTORANTA K ALAOPAS M PERTTILA I PETAS A RINTALA E SALMINEN R JUUSELA H HANSSON E VONWENDT R TUHKANEN K TALJA M NURMI M PUNTALA P PERMI J PUOLAKKA VM VIITANEN J GISLASON T EINARSSON GV ERI LM KARLSEN S HOLME P SIVERTSEN SM STEINSVIK E SERVOLL E URNES T MALME PA JOHANSEN TEB OMLAND H NAGELHUS J KLOSTER SE SKJEGGESTAD O VADA K MORTENSEN R NYBERG G PETTERSSON G WEDMAN L BRATELL S FOLMERZ P ZACKRISSON B DAHLGREN K TILLEGARD A AUS G BERGDAHL S HUGOSSON J HOLMQUIST B EK A RADEMARK C KRISTIANSEN P HERMANSSON CG PEDERSEN K OSCARSSON C KIHL B OLSSON JO NELVIN L LEISSNER KH LUNDSTAM S HJERTBERG H VARENHORST E ANDERSSON SO WINDAHL T SWARTZ R AHLBERG B GEDDA S ANDERSTROM C EDDELAND S HANSSON R STROGERG P ADOLFSSON J BAUER P KLEIST H STORM B RANCH T STRAVSNES H BREKKAN E EKLUND T KARLBERG L MALICE MP BRONEE V WENNERLUND P ERIKSSON LO AASERUD E LEHMUSSAARI J SUOMIN R GABRIEL MA
Citation: Jt. Andersen et al., CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY, Urology, 46(5), 1995, pp. 631-637
TESTICULAR HISTOLOGY AFTER TREATMENT WITH THE NEW ANTIANDROGEN CASODEX FOR CARCINOMA OF THE PROSTATE - A PRELIMINARY-REPORT
Authors: JOHANSEN TEB MAJAK M NESLAND JM
Citation: Teb. Johansen et al., TESTICULAR HISTOLOGY AFTER TREATMENT WITH THE NEW ANTIANDROGEN CASODEX FOR CARCINOMA OF THE PROSTATE - A PRELIMINARY-REPORT, Scandinavian journal of urology and nephrology, 28(1), 1994, pp. 67-70
EVIDENCE OF ANDROGEN RECEPTIVITY IN THE PATHWAY OF TESTICULAR DESCENTIN HUMANS - A POSTNATAL STUDY
Authors: JOHANSEN TEB KLEIN H
Citation: Teb. Johansen et H. Klein, EVIDENCE OF ANDROGEN RECEPTIVITY IN THE PATHWAY OF TESTICULAR DESCENTIN HUMANS - A POSTNATAL STUDY, European urology, 23(4), 1993, pp. 466-468
A BLADDER-CANCER MULTIINSTITUTIONAL EXPERIENCE WITH TOTAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER-CANCER
Authors: WOEHRE H OUS S KLEVMARK B KVARSTEIN B URNES T OGREID P JOHANSEN TEB FOSSA SD
Citation: H. Woehre et al., A BLADDER-CANCER MULTIINSTITUTIONAL EXPERIENCE WITH TOTAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER-CANCER, Cancer, 72(10), 1993, pp. 3044-3051
CLINICAL-SIGNIFICANCE OF DNA-PLOIDY AND S-PHASE FRACTION AND THEIR RELATION TO P53 PROTEIN, C-ERBB-2 PROTEIN AND HCG IN OPERABLE MUSCLE-INVASIVE BLADDER-CANCER
Authors: FOSSA SD BERNER AA JACOBSEN AB WAEHRE H KVARSTEIN B URNES T OGREID P JOHANSEN TEB SILDE J NESLAND JM PETTERSEN EO
Citation: Sd. Fossa et al., CLINICAL-SIGNIFICANCE OF DNA-PLOIDY AND S-PHASE FRACTION AND THEIR RELATION TO P53 PROTEIN, C-ERBB-2 PROTEIN AND HCG IN OPERABLE MUSCLE-INVASIVE BLADDER-CANCER, British Journal of Cancer, 68(3), 1993, pp. 572-578
Risultati: 1-7 |